Skip to main content
AAPA 2025 Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Invitation Only
Invitation Only
Ticketed - Complimentary
Ticketed - Complimentary
Ticketed - Additional Fee Required
Ticketed - Additional Fee Required
Capturing for On Demand
Capturing for On Demand
Pharmacology
Pharmacology
National Health Priorities
National Health Priorities
Potential State Requirement
Potential State Requirement
Project Innovation
Project Innovation
PA Administrative Competencies
PA Administrative Competencies

NEUR-Neurology

Satellite Symposium: Navigating Advances in Alzheimer’s Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care

Sunday, May 18, 2025
5:45 PM – 7:45 PM  
Location: Colorado Convention Center, Mile High Ballroom 1

This activity has been approved for 1.50 AAPA Category 1 CME credits.

Please click here to register to for this session to attend in person or virtually.

In this Cases in Practice workshop, participants will delve into the intricate relationship between key biomarkers of Alzheimer's disease (AD) neuropathology and the cognitive and functional changes that manifest as the disease progresses. By recognizing that the underlying pathology of AD can begin long before the appearance of clinical symptoms, the faculty will provide strategies for improving AD detection with biomarker testing to enable the potential to intervene before significant cognitive decline occurs. The expert panel will also explore the respective roles of symptomatic treatments and amyloid-targeting therapies in different stages of AD, driven by evidence that initiating treatment at the earliest symptomatic stages can slow disease progression. Patient cases will be used to illustrate the practicalities of how modern AD treatment approaches can be individualized and implemented in routine clinical care settings. Don’t miss this unique opportunity to update your knowledge and skills in the new era of disease-modifying therapy for AD

This CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE activity is provided by PVI, PeerView Institute for Medical Education.

This activity has been developed in partnership with BrightFocus Foundation.

This activity is supported by an educational grant from Lilly.

This symposium is neither supported, sponsored, nor endorsed by AAPA.

Learning Objectives:

At the conclusion of this session, participants should be able to:
  • Examine the relationship between key biomarkers of AD neuropathology and the cognitive and functional changes observed across the disease continuum
  • Describe the progression of AD from preclinical neuropathological changes to clinical dementia and the implications of this trajectory for prevention and early detection
  • Integrate new and emerging therapies and lifestyle interventions into clinical practice to promote brain health and manage cognitive decline across the AD continuum